Both conditions stimulate the release of pro-inflammatory molecules, making them potential targets for biological medications, like Infliximab or Humira which aim to calm down the immune response (4)
Historically, women have reached target values for modifiable CV risk factors, including HbA 1c , systolic and diastolic blood pressure, and lipid levels, less frequently than men [31,32,33]
Then the cycle repeats with your next weekly dose
It is not dramatic
Clinical trials, including SURPASS-2, have demonstrated significant improvements in HbA1c levels and substantial weight loss compared to other treatments, with effects becoming apparent within the first few weeks of treatment and continuing to improve over several months of consistent use